Search
31/12/2025
Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysis
Calle, C, Elez, E, Manzano, JL, Moreno-Martinez, ME, Pericay, C, Graefenhain, R, Ariznavarreta, A, Lizan, L. Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysis. Journal Of Pharmaceutical Policy And Practice. 2025; 18(1)DOI:10.1080/20523211.2025.2567970. PMID:41415036. IF:(Q/D).
27/12/2025
Lipoprotein-Specific Fatty Acid Profiles in Familial Hypercholesterolemia: Associations with Cardiovascular History and Dietary Patterns
López-Yerena, A, Arroyo-Olivares, R, Santisteban, V, Muñoz-Garcia, N, Estruch, R, Mata, P, Badimon, L, Padro, T. Lipoprotein-Specific Fatty Acid Profiles in Familial Hypercholesterolemia: Associations with Cardiovascular History and Dietary Patterns. Nutrients. 2025; 18(1)DOI:10.3390/nu18010092. PMID:41515209. IF:5.000(Q1/2D).
25/12/2025
Ultrasound-Enhanced Assessment of Vitreous Status in Exudative AMD: Associations with Neovascular Phenotypes, Treatment Burden, and Functional Outcomes
Rodriguez-Vidal, C, Pandelo, LG, Martínez-Alday, N, Bande, M, Teijeiro, MJB. Ultrasound-Enhanced Assessment of Vitreous Status in Exudative AMD: Associations with Neovascular Phenotypes, Treatment Burden, and Functional Outcomes. Journal of Clinical Medicine. 2025; 15(1)DOI:10.3390/jcm15010167. PMID:41517415. IF:2.900(Q1/2D).
24/12/2025
PTH Analog Therapy in CKD G4-G5D: Current Evidence and Potential Role of Abaloparatide in Adynamic Bone Disease
Gifre, L, Fusaro, M, Lloret, MJ, Massó, E, Peris, P, Nogués, X, Gelpi, R, Prior-Español, A, Ara, J, Cozzolino, M, Ureña-Torres, PA, Bover, J. PTH Analog Therapy in CKD G4-G5D: Current Evidence and Potential Role of Abaloparatide in Adynamic Bone Disease. Journal of Clinical Medicine. 2025; 15(1)DOI:10.3390/jcm15010133. PMID:41517382. IF:2.900(Q1/2D).